SCHEMBL24319450

SCHEMBL24319450

CCCCCN1CCN(COC[C@@H](O)CN2CCN(C)CC2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.48
GLA P06280 1/20 0.48
ALDH1A1 P00352 2/20 0.46
USP2 O75604 2/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MAPT P10636 1/20 0.43
LMNA P02545 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GNAI3 P08754 2/20 0.39
GNAO1 P09471 2/20 0.39
GNAI1 P63096 2/20 0.39
HTT P42858 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GAA P10253 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24319163 1.00 KDM4E (0.48) KDM4EGLAALDH1A1USP2ALOX15
SCHEMBL10509923 0.84 USP2 (0.49) KDM4EGLAALDH1A1USP2ALOX15
SCHEMBL13924017 0.83 KDM4E (0.55) KDM4EGLAALDH1A1USP2ALOX15
SCHEMBL11154511 0.82 KDM4E (0.58) KDM4EGLAALDH1A1USP2ALOX15
SCHEMBL10005231 0.82 KDM4E (0.64) KDM4EGLAALDH1A1USP2ALOX15
SCHEMBL21477058 0.80 KDM4E (0.57) KDM4EGLAALDH1A1USP2ALOX15
SCHEMBL21477194 0.80 KDM4E (0.57) KDM4EGLAALDH1A1USP2ALOX15
SCHEMBL18551052 0.78 KDM4E (0.58) KDM4EGLAALDH1A1USP2ALOX15
SCHEMBL18551060 0.78 KDM4E (0.58) KDM4EGLAALDH1A1USP2ALOX15
SCHEMBL26376109 0.78 KDM4E (0.58) KDM4EGLAALDH1A1USP2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022047145-A1 RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2022-03-03 WO disclosed